BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8936957)

  • 21. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
    Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents.
    Hyun SE; Lee BC; Suh BK; Chung SC; Ko CW; Kim HS; Lee KH; Yang SW; Shin CH; Hwang JS; Kim DH; Lim BK; Kim JD; Yoo HW; Kim HS; Chung WY; Park MJ; Woo YJ; Kim CJ; Lee DY; Kim EY; Choi JH; Han HS; Hwang IT; Kim HS
    Clin Biochem; 2012 Jan; 45(1-2):16-21. PubMed ID: 22032863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
    Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF binding proteins in growth-retarded children with chronic renal failure.
    Lee PD; Hintz RL; Sperry JB; Baxter RC; Powell DR
    Pediatr Res; 1989 Oct; 26(4):308-15. PubMed ID: 2552387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.
    Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K
    Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum propeptides of type I and III procollagens in renal transplant recipients. A comparison of cyclosporine and azathioprine treatment.
    Heickendorff L; Frost L; Madsen JK; Pedersen EB
    Nephron; 1994; 67(2):203-8. PubMed ID: 8072610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
    Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
    Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) for evaluation of children with short stature.
    Jaruratanasirikul S; Leethanaporn K; Sriplung H
    J Med Assoc Thai; 2000 Jun; 83(6):619-26. PubMed ID: 10932487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
    Argente J; Barrios V; Pozo J; Muñoz MT; Hervás F; Stene M; Hernández M
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum.
    Powell DR; Liu F; Baker B; Lee PD; Belsha CW; Brewer ED; Hintz RL
    Pediatr Res; 1993 Feb; 33(2):136-43. PubMed ID: 7679487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
    Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
    Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum.
    Durham SK; Mohan S; Liu F; Baker BK; Lee PD; Hintz RL; Conover CA; Powell DR
    Pediatr Res; 1997 Sep; 42(3):335-41. PubMed ID: 9284274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure.
    Lee DY; Cohen P; Krensky AM; Rosenfeld RG; Yorgin PD
    Pediatr Nephrol; 1993 Aug; 7(4):416-23. PubMed ID: 7691141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids.
    Wolthers OD; Heuck C; Ternowitz T; Heickendorff L; Nielsen HK; Frystyk J
    Dermatology; 1996; 192(4):337-42. PubMed ID: 8864369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
    Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
    J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.